Objective: To measure and compare care for adults with MS across managed ca
re and fee-for-service (FFS) health systems. Methods: The authors sampled a
dults with MS having physician visits over a a-year period from a group mod
el health maintenance organization (HMO) in southern California, from a mid
western independent practice association (IPA) model managed care plan, and
from the FFS portion of the practices of a random sample of southern Calif
ornia neurologists. The authors mailed surveys to subjects in mid-1996; 930
of 1,164 (80%) of those eligible responded. The authors measured sociodemo
graphic and clinical characteristics, management of recent changes in mobil
ity, bladder control, and fatigue, use of a disease-modifying agent, assess
ment of general health symptoms and issues, and unmet information needs. Th
e authors adjusted comparisons between systems for comorbidity, disease sev
erity, and disease type. Results: The groups differed on most sociodemograp
hic and clinical characteristics. There were few differences in symptom man
agement; differences that did exist tended toward more referrals or treatme
nt for the FFS group. Access to the disease-modifying agent available at th
e time of the survey did not differ across systems, although patients' perc
eptions of the rationale for not using the drug did vary. General health is
sues and symptoms were more often assessed in the FFS and IPA systems than
in the HMO, but improvement was needed across all three systems of care. Th
ere were substantial unmet information needs in all groups and especially h
igh ones in the FFS and HMO samples. Conclusions: Strategies to improve car
e for people with MS should be developed and evaluated, particularly in are
as like symptom assessment and meeting patient information needs. Where var
iations in service delivery exist, longitudinal studies are also needed to
evaluate the potential impact on outcomes and to evaluate reasons for varia
tion.